|
|
|
| Clinical analysis of ischemic colitis combined with mesenteric angiography |
| LIN Ruoyang1, XIA Yongsheng2,HUANG Zhiming1 |
| 1.Department of Gastroenterology and Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 2.Department of Ultrasonic, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China |
|
| Cite this article: |
|
LIN Ruoyang,XIA Yongsheng,HUANG Zhiming. Clinical analysis of ischemic colitis combined with mesenteric angiography[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2021, 51(11): 907-911,916.
|
|
|
|
Abstract Objective: To investigate the clinical characteristics of ischemic colitis and analyze the relationship between biochemical indexes, mesenteric CTA, mesenteric artery contrast-enhanced ultrasonography and endoscopic manifestations. Methods: Patients who were clinically diagnosed with ischemic colitis from February 2019 to October 2020 were enrolled, who were divided as mild group and severe group according to colonoscopy manifestations. The differences between the two groups were investigated and compared in clinical symptoms,biochemical examination, pathology of colonoscopy, mesenteric CTA, and angiography results. Results: Blood leukocyte count, prothrombin time, creatinine level and CRP level were significantly higher in severe group than in mild group (P<0.05), with statistical difference in mesenteric artery CTA examination between the mild and severe groups (P=0.014). The positive rate of mesenteric contrast-enhanced ultrasound was higher in severe group than in mild group, with no significant difference (P=0.108). The difference between the positive rate of mesenteric artery CTA and the positive rate of mesenteric artery contrast-enhanced ultrasound was statistically significant in all enrolled patients (P=0.035). Conclusion: The colonoscopy difference in patients with ischemic colitis is significantly related to white blood cell count, prothrombin time, creatinine, CRP level. The choice between mesenteric artery CTA and mesenteric artery contrast-enhanced ultrasound should be based on the patient's condition.
|
|
Received: 13 May 2021
|
| |
|
|
|
|
|
|
